ArticleOncoimmunology2016

Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies.

Elisa Cappuzzello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.